Journal
IMMUNOLOGY
Volume 150, Issue 4, Pages 456-467Publisher
WILEY
DOI: 10.1111/imm.12699
Keywords
bone marrow-derived mast cells; cytokine; inflammation; peroxisome proliferator-activated receptor-
Categories
Funding
- National Institutes of Health
- National Cancer Institute [R01-CA124533, R01-CA141029, 1ZIABC005561, 1ZIABC005562, 1ZIABC005708]
Ask authors/readers for more resources
The peroxisome proliferator-activated receptor-/ (PPAR/) is known to have multiple anti-inflammatory effects, typically observed in endothelial cells, macrophages, T cells and B cells. Despite the fact that mast cells are important mediators of inflammation, to date, the role of PPAR/ in mast cells has not been examined. Hence, the present study examined the hypothesis that PPAR/ modulates mast cell phenotype. Bone-marrow-derived mast cells (BMMCs) and peritoneal mast cells from Ppar/(+/+) mice expressed higher levels of high-affinity IgE receptor (Fc epsilon RI) compared with Ppar/(-/-) mice. BMMCs from Ppar/(+/+) mice also exhibited dense granules, associated with higher expression of enzymes and proteases compared with Ppar/(-/-) mice. Resting BMMCs from Ppar/(+/+) mice secreted lower levels of inflammatory cytokines, associated with the altered activation of phospholipase C1 and extracellular signal-regulated kinases compared with Ppar/(-/-) mice. Moreover, the production of cytokines by mast cells induced by various stimuli was highly dependent on PPAR/ expression. This study demonstrates that PPAR/ is an important regulator of mast cell phenotype.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available